Table 1 Serum and total blood count parameters at week 13.

From: Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy

Parameter (unit)

Groups

Sham

CKD

CKD + losartan

CKD + mirabegron

Serum sodium ion (mmol/L)

141 ± 0.7

140 ± 0.43

141 ± 0.62

141 ± 0.74

Serum potassium ion (mmol/L)

5.3 ± 0.16

4.97 ± 0.17

5.53 ± 0.15

5.23 ± 0.31

Serum chloride ion (mmol/L)

103 ± 0.95

103 ± 0.51

102 ± 0.45

101 ± 1.07

Serum phosphate ion (mmol/L)

2.28 ± 0.15

2.31 ± 0.1

2.22 ± 0.06

2.46 ± 0.13

Serum calcium ion (mmol/L)

2.44 ± 0.01

2.54 ± 0.04*

2.58 ± 0.02*

2.59 ± 0.02*

Serum magnesium ion (mmol/L)

0.9 ± 0.02

0.97 ± 0.04

1.03 ± 0.04

1.29 ± 0.12*#

Serum total cholesterol (mmol/L)

1.56 ± 0.03

2.23 ± 0.2*

2.65 ± 0.12*

4.11 ± 0.22*#

Serum LDL-cholesterol (mmol/L)

0.53 ± 0.04

0.79 ± 0.08*

0.73 ± 0.03*

1.16 ± 0.11*#

Serum triglyceride (mmol/L)

0.52 ± 0.03

0.6 ± 0.07

0.77 ± 0.12

0.99 ± 0.1*#

Red blood cells (1012/L)

8.3 ± 0.11

7.25 ± 0.23*

7.09 ± 0.22*

6.55 ± 0.32*

Hematocrit (%)

44 ± 1

39 ± 1*

39 ± 1*

36 ± 1*#

Hemoglobin (g/L)

148 ± 2.29

131 ± 4.2*

131 ± 2.26*

120.14 ± 4.58*

White blood cells (109/L)

3.45 ± 0.23

6.63 ± 0.87*

4.47 ± 0.45#

6.57 ± 0.6*

  1. Values are presented as mean ± S.E.M., *p < 0.05 vs. sham-operated group, #p < 0.05 vs. CKD group (n = 6–10 for serum parameters, n = 5–8 for blood count parameters, One-Way ANOVA, Holm-Sidak post hoc test).
  2. Sham sham-operated group, CKD chronic kidney disease group.